In 2019, “value” may be the most overused yet least agreed upon term in our health care lexicon. On the surface, most stakeholders align on an aspirational definition of value: the right treatment for the right patient in the right setting at the right time. But all too often, legacy mistrust, siloed perspectives, and competing incentives impede the advancement of common definitions or shared frameworks for truly assessing value in U.S. health care.

In an effort to break down industry barriers and encourage more honest dialogue, Advisory Board is hosting its first-ever Cross-Industry Value Summit:

  • When? Tuesday, September 24, 2019 from 8:00 a.m.– 4:30 p.m. (optional welcome dinner Monday evening, Sept. 23)
  • Where? 655 New York Ave NW, Washington, DC 20001
  • Who’s going? This invite-only event will convene 30–40 medical and pharmacy leaders from across the health care ecosystem—payers, providers, employers as well as third party “technology assessment” organizations increasingly opining on the value of new treatments
Want to join the conversation?
Fill out the form below and we will get in touch with you regarding the Cross-Industry Summit.

*
*
*
*
*

Event Agenda:
Through panels, networking sessions, and expert-led workshops, participants will discuss how they define, measure, and drive medical value—while also identifying ways to build trust and transparency around both evidence generation and broader models for cross-sector collaboration.

Download the full agenda

What to ExPect:

Build bridges across industry silos

Participate in a structured dialogue with forward-thinking leaders—listen with an open mind, ask difficult questions, and share honest perspectives

Surface meaningful cross-industry definitions of value

Engage directly with other stakeholders on complex questions to acknowledge biases and identify shared points of view

Identify feasible opportunities to collaborate on measuring value

Discuss how near-term capabilities and innovations in data, analytics, and digital tools can track and catalyze real world outcomes tracking

agenda

">

Agenda

Tuesday, Sept. 24, 2019 | 8:00 a.m. - 4:30 p.m.


Keynote Address: The value conundrum


Panel Discussions: Perspectives on Value

Redefining HTAs: Meet the new KOLs on value
Hear how thought leaders are actively defining shared value frameworks and bringing objectivity to a complex health care ecosystem. 

The new integrated delivery network
Hear how thought leaders are actively defining shared value frameworks and bringing objectivity to a complex health care ecosystem. 

Small Group Working Sessions

Join participants from across the health care ecosystem in candid conversations about root cause problems, barriers to trust and transparency, and disruptive opportunities to “flip the script.”

  • Develop digital solutions to shared education and adherence challenges
  • Prepare for accelerating site of care shifts
  • Leverage the predictive power of Google/Apple/Amazon
  • Use social determinants to establish unmet need and demonstrate population health outcomes
  • Compare relative value of medication, procedural, or lifestyle interventions
  • Build collaborative RWE models using EHR network

Closing Address: Advancing the conversation—the jobs to be done

Featured experts

Sunil S. Budhrani, MD, MPH, MBA

CEO/CMO,
Innovation Health

Elke S. Nelson-Nichols, PhD, MBA

Director, Strategic Initiatives,
ECRI Institute

Leslie Fish, R.Ph, Pharm.D.

Director of Clinical Pharmacy,
IPD Analytics

Madhavi Kasinadhuni

Director of Research,
Advisory Board

Efrem Castillo, MD

Chief Medical Officer, UnitedHealthcare Medicare and Retirement

Alex C. McLaren, MD

Vice President of Clinical Outcomes, SharedClarity

Brandi Greenberg

Director of Research,
Advisory Board

Lee Scheinbart, MD

Chief Medical Officer,
Health First

Hani Elias, JD, MPH

Chief Executive Officer,
Lumere

Dave Willis

Director of Research,
Advisory Board